Perspective Share Price

Perspective Share Price

AMEX: CATX | Micro Cap | Healthcare
$0.78
-$0.08 (-9.35%) Last updated on 19 Nov, 2026 | 02:29 IST
  • Performance
  • Chart
  • Fundamentals
  • Profit & Loss
  • Balance Sheet
  • Cash Flow
  • Corporate Actions
  • About
  • Price history
  • FAQs

Perspective Stock Performance

Open
$0.86
Prev. Close
$0.86
Circuit Range
N/A
Day Range
$0.78 - $0.87
Year Range
$0.78 - $6.16
Volume
90,107
Average Traded
$0.82

Perspective Share Price Today

As of 19 November 2026, Perspective Therapeutics, Inc.'s share price is $0.78. The stock opened at $0.86, compared to its previous close of $0.86. During today's trading session, Perspective Therapeutics, Inc.'s share price traded between $0.78 and $0.87, with an average price of $0.82. Over the past 52 weeks, the stock has recorded a high of $6.16 and a low of $0.78. In terms of performance, Perspective Therapeutics, Inc.'s share price has declined by 80.23% over the last six months and is down 66.94% on a year-on-year basis.

Perspective Share Price Chart

Line chart of the Perspective price trend over the selected period. The price fell overall, ranging from 0.78 to 0.87, ending at 0.78.
$0.78$0.87
L
Show Current Price
H

Perspective Stock Fundamentals & Key Indicators

Market Cap
$57.58M
PE Ratio (TTM)
N/A
Dividend Yield
0.00%
EPS (TTM)
$-1.02
Revenue (TTM)
$880.00M
Return On Equity (TTM)
-41.71%
Profit Margin
-11718.18%
Debt to Equity
0.01
Quarterly Earnings Growth YoY
13.47%

Perspective Quarterly Profit & Loss

All figures in USD

ParticularsDec 2025Mar 2026Jun 2026Sep 2026
Revenue$0.04$0.08$0.08$0.02
Net Profit-$37.49-$26.19-$26.79-$32.44
Net Profit Margin-93725.00%-32737.50%-33487.50%-162200.00%
Income ChangeN/A30.14%-2.29%-21.09%

Perspective Annual Profit & Loss

All figures in USD

Particulars202320242025
Revenue$1.43$1.45$0.88
Net Profit-$46.51-$79.28-$103.12
Net Profit Margin-3252.45%-5467.59%-11718.18%
Income ChangeN/A-70.46%-30.07%

Perspective Balance Sheet

All figures in USD Million

Particulars202520242023
Non Current Assets118.58109.9481.05
Current Assets148.39231.1616.84
Total Assets266.97341.197.89
Non Current Liabilities31.2632.212.12
Current Liabilities28.6818.2310.59
Total Liabilities59.9450.4322.71
Shareholders' Equity207.03290.6775.18

Perspective Cash Flow

Annually

All figures in USD Million

Particulars202520242023
Operating-82.48-18.29-36.91
Investing41.23-218.9324.37
Financing10.31289.390.79

Corporate Actions

Split
Ex-date: 17 Jun 2024

About Perspective

Perspective Therapeutics Inc is a radiopharmaceutical development company that is pioneering advanced treatment applications for cancers throughout the body. The Company has a proprietary technology that utilizes the alpha-emitting isotope Lead-212 (212Pb) to deliver powerful radiation specifically to cancer cells via specialized targeting moieties.

Perspective Historical Returns

Share price history by day, with open and close prices and the day's change
MonthOpenCloseChange %
Nov 2026
$1.15
$0.78
-30.97%
Oct 2026
$2.69
$1.13
-58.83%
Sep 2026
$3.16
$2.75
-13.41%
Aug 2026
$2.88
$3.17
+9.69%
Jul 2026
$3.43
$2.89
-15.12%
Jun 2026
$3.87
$3.40
-13.69%
May 2026
$3.90
$3.94
+1.15%
Apr 2026
$4.16
$3.90
-6.47%
Mar 2026
$5.12
$4.17
-22.63%
Feb 2026
$4.14
$5.39
+42.59%
Jan 2026
$2.75
$3.78
+37.45%
Dec 2025
$2.29
$2.75
+16.53%

Perspective Share Price FAQs